CEACAM5 and familial pancreatic carcinoma: Herein, we demonstrate, for the first time to our knowledge, that dCAR-modified T cell exerts effective and safe cytotoxicity for the treatment of pancreatic cancer cell expressing the tumor antigens CEA and MSLN in vitro and in vivo.